Genetic Technologies
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $2,399 | $2,399 | $3,958 | $2,436 |
Gross Profit | 1,397 | 1,397 | -1,981 | 1,558 |
EBITDA | -2,588 | -2,588 | -4,882 | -2,441 |
EBIT | -2,715 | -2,715 | -5,163 | -2,581 |
Net Income | -2,798 | -2,798 | -6,419 | -3,209 |
Net Change In Cash | 2,399 | 2,399 | 3,958 | 2,436 |
Free Cash Flow | -2,836 | -1 | -3,902 | -2,026 |
Cash | 1,020 | 1,020 | 3,729 | 3,729 |
Basic Shares | 149,017 | 149,017 | 120,785 | 115,417 |
Annual Financials
| Values in thousands | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|
Revenue | $7,664 | $8,686 | $6,794 | $120 |
Gross Profit | 3,904 | 4,350 | 6,473 | -240 |
EBITDA | -11,430 | -9,238 | -3,712 | -7,063 |
EBIT | -11,965 | -9,915 | -4,291 | -7,063 |
Net Income | -12,017 | -11,750 | -7,130 | -7,207 |
Net Change In Cash | 7,664 | 8,686 | 6,794 | 120 |
Free Cash Flow | -9,712 | -9,951 | -6,649 | -7,198 |
Cash | 1,020 | 7,851 | 11,731 | 20,902 |
Basic Shares | 132,217 | 101,380 | 92,203 | 85,441 |
Earnings Calls
| Quarter | EPS |
|---|---|
2023-12-31 | $0 |
2023-09-30 | $0 |
2023-06-30 | $0 |
2023-03-31 | $0 |
